[Retracted] A Case‐Control Study of Continuous Veno‐Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis

Yan Liu, Bing Wang, Qian Zhang, Yuliang Zhao, Xudong Wang

Open source

DOI
10.1155/2022/7884508
Published
2022-01
Container
Contrast Media & Molecular Imaging
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/7884508,
  title = {[Retracted] A Case‐Control Study of Continuous Veno‐Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis},
  author = {Yan Liu and Bing Wang and Qian Zhang and Yuliang Zhao and Xudong Wang},
  year = {2022},
  journal = {Contrast Media \& Molecular Imaging},
  doi = {10.1155/2022/7884508},
  url = {https://doi.org/10.1155/2022/7884508}
}

RIS

TY  - JOUR
TI  - [Retracted] A Case‐Control Study of Continuous Veno‐Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis
AU  - Yan Liu
AU  - Bing Wang
AU  - Qian Zhang
AU  - Yuliang Zhao
AU  - Xudong Wang
PY  - 2022
JO  - Contrast Media & Molecular Imaging
DO  - 10.1155/2022/7884508
UR  - https://doi.org/10.1155/2022/7884508
ER  - 

APA

Liu, Y., Wang, B., Zhang, Q., Zhao, Y., & Wang, X. (2022). [Retracted] A Case‐Control Study of Continuous Veno‐Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis. Contrast Media & Molecular Imaging. https://doi.org/10.1155/2022/7884508

Source records